NeuPath Ebit from 2010 to 2026

NPTH Stock  CAD 0.52  0.01  1.96%   
NeuPath Health EBIT yearly trend continues to be fairly stable with very little volatility. EBIT will likely drop to about -1.5 M in 2026. During the period from 2010 to 2026, NeuPath Health EBIT regression line of quarterly data had r-squared of  0.53 and coefficient of variation of (38.43). View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
-1.4 M
Current Value
-1.5 M
Quarterly Volatility
704.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeuPath Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuPath Health's main balance sheet or income statement drivers, such as Interest Expense of 960.6 K, Income Tax Expense of 234.3 K or Tax Provision of 137.1 K, as well as many indicators such as . NeuPath financial statements analysis is a perfect complement when working with NeuPath Health Valuation or Volatility modules.
  
This module can also supplement various NeuPath Health Technical models . Check out the analysis of NeuPath Health Correlation against competitors.

Latest NeuPath Health's Ebit Growth Pattern

Below is the plot of the Ebit of NeuPath Health over the last few years. It is NeuPath Health's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeuPath Health's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

NeuPath Ebit Regression Statistics

Arithmetic Mean(1,833,236)
Coefficient Of Variation(38.43)
Mean Deviation637,397
Median(1,841,000)
Standard Deviation704,581
Sample Variance496.4B
Range1.8M
R-Value0.73
Mean Square Error249B
R-Squared0.53
Significance0.0009
Slope101,555
Total Sum of Squares7.9T

NeuPath Ebit History

2026-1.5 M
2025-1.4 M
2022-1.3 M
2021-1.8 M
2020-820 K
2019-661 K
2018-1 M

About NeuPath Health Financial Statements

NeuPath Health investors use historical fundamental indicators, such as NeuPath Health's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NeuPath Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-1.4 M-1.5 M
EBITDA-671.6 K-705.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.